World's Best Scientists 2026 revealed!
James A. Karlowsky

James A. Karlowsky

D-Index & Metrics

Microbiology

D-Index
88
Citations
26684
World Ranking
763
National Ranking
18

Overview

James A. Karlowsky is affiliated with the University of Manitoba in Canada and has made significant contributions to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields, including Epidemiology, Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, and Infectious Diseases.

The scientist's work focuses extensively on topics related to antibiotic resistance and bacterial infections. Main topics covered include:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • Bacterial Identification and Susceptibility Testing
  • Urinary Tract Infections Management
  • Antimicrobial Resistance in Staphylococcus

James A. Karlowsky has published in various peer-reviewed venues, with the most frequent venues including:

  • Journal of Antimicrobial Chemotherapy
  • Journal of Global Antimicrobial Resistance
  • Antimicrobial Agents and Chemotherapy
  • Diagnostic Microbiology and Infectious Disease
  • JAC-Antimicrobial Resistance

Their recent papers illustrate active involvement in antimicrobial resistance research and clinical infectious diseases:

  • In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017 (2020), Clinical Infectious Diseases
  • Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent (2020), Drugs
  • Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017 (2021), Antimicrobial Agents and Chemotherapy
  • Infective Endocarditis in Patients on Chronic Hemodialysis (2021), Journal of the American College of Cardiology
  • In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017 (2020), Journal of Medical Microbiology

Frequent collaborators of James A. Karlowsky include:

  • George G. Zhanel
  • Melanie Baxter
  • Heather J. Adam
  • Andrew Walkty
  • Philippe Lagacé-Wiens

James A. Karlowsky's research contributions focus primarily on understanding and addressing antimicrobial resistance in clinical settings, with an emphasis on the pharmacokinetics and efficacy of antibiotics as well as identification and susceptibility testing of bacterial pathogens.

Best Publications

  • Comparative review of the carbapenems.

    George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

  • Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System

    Christine Y. Turenne;Steven E. Sanche;Daryl J. Hoban;James A. Karlowsky

  • Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

    James A. Karlowsky;Deborah C. Draghi;Mark E. Jones;Clyde Thornsberry

  • Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

    George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer

  • Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

    Daniel F. Sahm;Clyde Thornsberry;David C. Mayfield;Mark E. Jones

  • New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

    George G. Zhanel;Divna Calic;Frank Schweizer;Sheryl Zelenitsky

  • Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

    George G. Zhanel;Alyssa R. Golden;Sheryl Zelenitsky;Karyn Wiebe

  • Review of macrolides and ketolides: focus on respiratory tract infections

    George G. Zhanel;Maria Dueck;Daryl J. Hoban;Lavern M. Vercaigne

  • The glycylcyclines: a comparative review with the tetracyclines.

    George G Zhanel;Kristen Homenuik;Kim Nichol;Ayman Noreddin

  • Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

    Mark E Jones;Deborah C Draghi;Clyde Thornsberry;James A Karlowsky

  • Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

    George G. Zhanel;Courtney K. Lawrence;Heather Adam;Frank Schweizer

  • Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

    George G. Zhanel;Tamiko L. Hisanaga;Nancy M. Laing;Melanie R. DeCorby

  • Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

    George G. Zhanel;George G. Zhanel;Phillip Chung;Heather Adam;Heather Adam;Sheryl Zelenitsky

  • Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

    George G. Zhanel;Mel DeCorby;Nancy Laing;Barb Weshnoweski

  • Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

    Clyde Thornsberry;Daniel F. Sahm;Laurie J. Kelly;Ian A. Critchley

  • In Vitro Antimicrobial Resistance of Urinary Escherichia coli Isolates among U.S. Outpatients from 2000 to 2010

    Guillermo V. Sanchez;Ronald N. Master;James A. Karlowsky;Jose M. Bordon

  • Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

    Mark E. Jones;James A. Karlowsky;Deborah C. Draghi;Clyde Thornsberry

  • Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

    George G. Zhanel;George G. Zhanel;Doris Cheung;Heather J. Adam;Heather J. Adam;Sheryl A. Zelenitsky

  • Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

    James A Karlowsky;Mark E Jones;Deborah C Draghi;Clyde Thornsberry

  • Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the

    James A. Karlowsky;Laurie J. Kelly;Clyde Thornsberry;Mark E. Jones

Frequent Co-Authors

George G. Zhanel
George G. Zhanel University of Manitoba
Daryl J. Hoban
Daryl J. Hoban University of Manitoba
Andrew Walkty
Andrew Walkty University of Manitoba
Heather J. Adam
Heather J. Adam University of Manitoba
Philippe R. S. Lagacé-Wiens
Philippe R. S. Lagacé-Wiens University of Manitoba
Mark E. Jones
Mark E. Jones Basilea Pharmaceutica (Switzerland)
Clyde Thornsberry
Clyde Thornsberry Centers for Disease Control and Prevention
Michael R. Mulvey
Michael R. Mulvey University of Manitoba
Ian A. Critchley
Ian A. Critchley Spero Therapeutics (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to diverse online degrees and career pathways beyond traditional lab roles. For those interested in healthcare and direct patient support, becoming a child life specialist is a rewarding option. This profession combines knowledge of human development and emotional support, often aided by science-based education.

Students with unique backgrounds might benefit from programs highlighted in the best degree for felons guide, illustrating that career advancement is possible despite past challenges. Online microbiology-related degrees can be part of this inclusive educational landscape.

For those blending holistic healthcare with microbiology, pathways like how to become a functional medicine nurse practitioner show promising potential. This field emphasizes understanding complex biological systems and integrating alternative medical approaches.

Additionally, careers in healthcare administration and coding are growing. Understanding medical data and billing, as explained in the cpc salary article, can lead to stable careers that complement scientific expertise. Online degrees can prepare students for these varied opportunities.

Best Scientists Citing James A. Karlowsky

Trending Scientists